Here in this article the justification of expediency of enzyme resistant starch use in therapeutic food products is presented . Enzyme resistant starch is capable to resist to enzymatic hydrolysis in a small intestine of a person, has a low glycemic index, leads to decrease of postprandial concentration of glucose, cholesterol, triglycerides in blood and insulin reaction, to improvement of sensitivity of all organism to insulin, to increase in sense of fulness and to reduction of adjournment of fats. Resistant starch makes bifidogenшс impact on microflora of a intestine of the person, leads to increase of a quantity of lactobacillus and bifidobacterium and to increased production of butyric acid in a large intestine. In this regard the enzyme resistant starch is an important component in food for prevention and curing of human diseases such as diabetes, obesity, colitis, a cancer of large and direct intestine. One method is specified by authors for imitation of starch digestion in a human body. This method is based on the definition of an enzyme resistance of starch in vitro by its hydrolysis to glucose with application of a glucoamylase and digestive enzyme preparation Pancreatin. This method is used in researches of an enzyme resistance of starch, of genetically modified potato, high amylose corn starch Hi-Maize 1043 and HYLON VII (National Starch Food Innovation, USA), amylopectin and amylose. It is shown that the enzyme resistance of the starch emitted from genetically modified potatoes conforms to the enzyme resistance of the high amylose corn starch “Hi-Maize 1043 and HYLON VII starch”, (National Starch Food Innovation, the USA) relating to the II type of enzyme resistant starch. It is established that amylopectin doesn't have the enzyme resistant properties. The results of researches are presented. They allow us to make the following conclusion: amylose in comparison with amylopectin possesses higher enzyme resistance and gives to potatoes starch the increased enzyme resistant properties.

genetically modified potato, starch, amylose, amylopectine, enzyme resistance

1. Nugent A.P. // Nutr. Bull. 2005. №30. P. 27–54.

2. Fuentes-Zaragoza E., Sanchez-Zapata E., Sendra E., Sayas E. et al. Starch-Stärke. 2011. №63. P. 406–415.

3. Higgins J.A., Brown M.A., Storlien L.H. Consumption of resistant starch decreases postprandial lipogenesis in white adipose tissue of the rat // Nutrition Journal. 2006. № 5:25.

4. Robertson J.A., Ryden P., Ring S.G. Unavailable carbohydrates: behavior during digestion and consequences for fermentation // Res. Adv. Agri. Food Chem. 2000. №1. Р. 59-71.

5. Wang X., Gibson G.R. // J Appl. Bacteriol. 1993. № 75. Р. 373–386.

6. Topping D.L., Fukushima M., Bird A.R. Resistant starch as a prebiotic and synbiotic: state of the art // Proceedings of the Nutrition Society. 2003. № 62. Р. 171-176.

7. Silvi S., Rummey C.J., Cresci A., Rowland I.R. //J Appl. Microbiol. 1999. №86. Р. 521-530.

8. Pryde S.E., Duncan S.H., Hold G.L., StewartC.S. et al. // FEMS Microbiol. Left. 2002. № 217. Р. 133-139.

9. DuPont A.W., DuPont H.L. // Nat. Rev. Gastroenterol Hepatol. 2011. №8. Р. 523–531.

10. Holmes E., Kinross J., Gibson G.R., Burcelin R. et al. // Sci. Transl. Med. 2012. № 6. Р. 137.

11. Leszczynski W. Resistant starch classification, structure, production // Polish Journal of Food and Nutrition Sciences. 2004. № 1. Р. 37-50.

12. Nikitina E.V., Gabdukaeva L.Z., Reshetnik O.A .Resistance modified potato starches, processed alpha and beta-amylase. Herald seemed University of Technology, 2010, no.10, pp. 382-387. (In Russ.).

13. Nikitina E.V., Gabdukaeva L.Z., Gubaidullin R.A. The effect of treatment of alpha or beta amylase for technological and morphological properties of potato starch. Herald seemed University of Technology, 2013, no. 14, pp 148-150. (In Russ.).

14. Yagofarov D.V. Diss. Cand. thech. sci. Voronezh: Voronezh State University, 2012. 168 p. (In Russ.).

15. Suchkov T.N. Abstr. diss. cand. biol. sci. Voronezh: Voronezh State University, 2009. 22 p. (In Russ.).

16. Method for controlling glucose and ensuring its controlled supply and a food product for implementing. Patent RF, no. 2311798, 2007. (In Russ.).

17. Kolesnov A.Yu. Biochemical system in the evaluation of the quality of food products (enzymatic hydrolysis). Moscow, Food Industry, 2000. 416 p. (In Russ.).

18. Gamayurova V.S., Zinoviev M.E. Enzymes. Laboratory workshop. Sent-Petersburg, Science Prospect, 2011. 256 p. (In Russ.).